Health Reporter French Polynesia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Reporter French Polynesia.

Press releases published on August 4, 2026

an hour ago

ABLi Therapeutics Announces Outcomes from its Parkinson’s-related Biomarker Study Demonstrating Modification of Human Disease with Risvodetinib

Indeterminate GlobeNewswire

an hour ago

IMUNON to Hold Second Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, August 11, 2026

Indeterminate GlobeNewswire

an hour ago

Mineralys Therapeutics to Announce Second Quarter 2026 Financial Results and Host Conference Call on Tuesday, August 11, 2026

Indeterminate GlobeNewswire

an hour ago

FDA clears Healis Therapeutics’ IND for Tyemvers®, Enabling U.S. Neuropsychiatric Trials

Indeterminate GlobeNewswire

an hour ago

Cirrus Therapeutics Strengthens Its Position as a Next-Generation Global Ocular Immunology Leader with Singapore Eye Research Institute (SERI) Collaboration and Additional Financing

Indeterminate GlobeNewswire

an hour ago

SHY Therapeutics Announces the First Patient Has Been Dosed in Phase 1 Clinical Trial Evaluating SHY-ONC6, a Novel, Oral Proteasome Inhibitor for the Treatment of Solid Tumors

Indeterminate GlobeNewswire

an hour ago

Galectin Therapeutics Announces Conversion of $105.8 Million in Debt to Equity, Significantly Strengthening Balance Sheet

Indeterminate GlobeNewswire

an hour ago

Teleflex Medical OEM Launches as INGENYX to Empower Tomorrow’s MedTech Innovators

Indeterminate GlobeNewswire

an hour ago

Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026

Indeterminate GlobeNewswire

an hour ago

Rani Therapeutics Appoints Michelle Gilson to Board of Directors

Indeterminate GlobeNewswire

an hour ago

Exagen Inc. Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

an hour ago

Rein Therapeutics Announces Publication of Landmark LTI-03 Clinical Data in Nature Communications

Indeterminate GlobeNewswire

an hour ago

Medvantx Opens New Louisville Facility Expanding Capacity for Pharmacy Fulfillment

Indeterminate GlobeNewswire

an hour ago

YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research

Indeterminate GlobeNewswire

an hour ago

Medela Marks World Breastfeeding Week with Research Contribution and Educational Campaign

Indeterminate GlobeNewswire

an hour ago

Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

an hour ago

Leads Biolabs Announces Partner Oblenio Bio Doses First Patients in Phase 1a Trial of LBL‑051 for Refractory Autoimmune Diseases

Indeterminate GlobeNewswire

2 hours ago

Zevra Therapeutics to Present at the Canaccord Genuity Annual Growth Conference

Indeterminate GlobeNewswire

2 hours ago

CMS Grants New Technology Add-On Payment (NTAP) Status for ZEVASKYN®

Indeterminate GlobeNewswire

2 hours ago

Palvella Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire